EcoDrugPlus

Inosine-5'-Monophosphate Dehydrogenase 1b

Ensembl ID : ENSSTUG00000020282
Gene Symbol: LOC115199097
3 Cross references
252 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 2

Ensembl ID : ENSSTUG00000036551
Gene Symbol: LOC115168300
3 Cross references
194 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSSTUG00000011980
Gene Symbol: IGF1R
3 Cross references
200 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSSTUG00000028389
Gene Symbol: INSR
3 Cross references
204 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSSTUG00000036381
Gene Symbol: LOC115192162
3 Cross references
205 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSSTUG00000041599
Gene Symbol: LOC115157526
3 Cross references
204 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSSTUG00000006907
Gene Symbol: LOC115169288
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSSTUG00000037414
Gene Symbol: LOC115151978
3 Cross references
197 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSSTUG00000046953
Gene Symbol: LOC115196778
3 Cross references
198 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSSTUG00000034570
Gene Symbol: LOC115182685
3 Cross references
201 Possible Orthologues:

Integrin Alpha-4-Like

Ensembl ID : ENSSTUG00000039453
Gene Symbol: LOC115179184
2 Cross references
164 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSSTUG00000004713
Gene Symbol: LOC115165649
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).